Tumor proportion score (TPS) and response to first-line (1L) anti–PD-1/PD-L1 plus chemotherapy for metastatic non-small cell lung cancer (NSCLC): A real-world cohort study.

Authors: Imi Faghmous, Antonio Nicoale, Parameswaran N Hari, Giridharan Ramsingh

Published: 2025-05-28

DOI: 10.1200/jco.2025.43.16_suppl.e20606

Source: Full article

e20606